Euractiv.com

“Anyone’s better than Scholz”

If the predictions come true, Merz and his party are likely to play a key role in the negotiations to form a government, with the coalition agreement set to decide the fate of the pharmaceutical sector.

Euractiv sat down with MEP Anna Cavazzini, who has chaired the IMCO Committee in the Parliament since 2019, to speak about e-commerce goods and digital priorities this mandate.

The move deepens a feud between the two leaders that has alarmed European officials.

Sources: European leaders remain divided on whether to send their own envoy to the US-Russia talks.

A new study found that over 80 per cent of journalists surveyed use AI, with 42 per cent expressing optimism about its future role.

Pictures can be worth a thousand medical words and can help increase drug compliance, so new pictograms on medicine packaging have been launched in the Netherlands. A wider EU roll-out is anticipated.

Maroš Šefčovič's remarks came just hours before a high-stakes meeting with senior US officials.

Even so, the head of the Commission's AI Office expects no “big review” of the AI Act.

But the EU executive offered little clarity in response.

Tobacco, the US’ departure from the world body, and mental health were on the table during the debate.

Far from Wall Street, it is now up to Macron to convince his fellow citizens that manufacturing in France is more than a pipe dream.

Bruegel cites the US Energy Information Administration, set up after the first oil shock in the 1970s, which centrally collects energy data.

The MEPs said the decision to withdraw the proposal was ''politically misguided''. 

The European Commission's freshly released 'vision' for agriculture and food has tried to please many, but some nonetheless slammed the blueprint as too vague, too timid and not reflecting feedback.

Europe stands at a crossroads. The Clean Industrial Deal could drive a fair, competitive transition—or sideline industries and communities that rely on diverse energy solutions.

R&I spending should “contribute to Union priorities, but on the terms of science and innovation rather than on the terms of policymakers,” reads an ITRE committee report.

With just eight days left to finalise the agreement for the World Health Assembly in May, there are concerns that the EU is trying to shape the draft text with little benefit to developing countries.

One European official said that it is “very likely” that the EU’s sanctions policy “could evolve independently” of the US over the coming months.

This anti-reform shift could soon gain momentum as Germany's elections on 23 February approach.